ReviewCurrent pharmaceutical design2025
Artificial Intelligence in Medicine and Imaging Applications.
Review in Current pharmaceutical design, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Artificial intelligence (AI) can completely transform drug development methods by delivering faster, more accurate, efficient results. However, the effective use of AI requires the accessibility of data of excellent quality, the resolution of ethical dilemmas, and an awareness of the drawbacks of AI-based techniques. Moreover, the application of AI in drug discovery is gaining popularity as an alternative to both the complex and time-consuming process of discovering as well as developing novel medications. Importantly, machine learning (ML) as well as natural language processing, for example, may boost both productivity as well as accuracy by analyzing vast volumes of data. This review article discusses in detail the promise of AI in drug discovery as well as offers insights into various topics such as societal issues related to the application of AI in medicine (e.g., legislation, interpretability and explainability, privacy and anonymity, and ethics and fairness), the importance of AI in the development of drug delivery systems, causability and explainability of AI in medicine, and opportunities and challenges for AI in clinical adoption, threat or opportunity of AI in medical imaging, the missing pieces of AI in medicine, approval of AI and ML-based medical devices.
Indexed as
Identifiers
40353469What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.